A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Conditions: Recurrent Acute Leukemia of Ambiguous Lineage; Recurrent Acute Lymphoblastic Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Refractory Acute Leukemia of Ambiguous Lineage; Refractory Acute Lymphoblastic Leukemia; Refractory Mixed Phenotype Acute Leukem ia Interventions: Procedure: Biospecimen Collection; Drug: Calaspargase Pegol-mknl; Drug: Cytarabine; Procedure: Echocardiography; Drug: Fludarabine Phosphate; Drug: Hydrocortisone Sodium Succinate; Drug: Methotrexate; Procedure: Multigated Acquisition Scan; Drug: Pegasparg ase; Drug: Prednisolone; Drug: Prednisone; Drug: Revumenib; Drug: Vincristine Sulfate Sponsor: Children's Oncology Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chemotherapy | Children | Leukemia | Mergers and Aquisitions | Methotrexate | PET Scan | Prednisolone | Prednisone | Research | Study